Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ron Firestein

Showing results (41-50 of 65) with videos related to

Pageof 7
Sort By:
Molecular Cell|December 15, 2021
MED12 and BRD4 cooperate to sustain cancer growth upon loss of mediator kinaseDhanya Sooraj, Claire Sun, Anh Doan, et al.
The Journal of Clinical Investigation|August 25, 2022
CDK8 and CDK19 regulate intestinal differentiation and homeostasis via the chromatin remodeling complex SWI/SNFMarius V Dannappel, Danxi Zhu, Xin Sun, et al.
Cancer Research|March 30, 2013
A novel tankyrase small-molecule inhibitor suppresses APC mutation-driven colorectal tumor growthTed Lau, Emily Chan, Marinella Callow, et al.
Cell Metabolism|July 26, 2018
Pan-Cancer Metabolic Signature Predicts Co-Dependency on Glutaminase and De Novo Glutathione Synthesis Linked to a High-Mesenchymal Cell StateAnneleen Daemen, Bonnie Liu, Kyung Song, et al.
Molecular Cancer Therapeutics|September 25, 2014
An antimesothelin-monomethyl auristatin e conjugate with potent antitumor activity in ovarian, pancreatic, and mesothelioma modelsSuzie J Scales, Nidhi Gupta, Glenn Pacheco, et al.
Oncotarget|March 31, 2016
ImmunoPET helps predicting the efficacy of antibody-drug conjugates targeting TENB2 and STEAP1Simon-Peter Williams, Annie Ogasawara, Jeff N Tinianow, et al.
Nature|December 25, 2015
Targeting PTPRK-RSPO3 colon tumours promotes differentiation and loss of stem-cell functionElaine E Storm, Steffen Durinck, Felipe de Sousa e Melo, et al.
Genome Biology|December 9, 2023
Pediatric glioma histone H3.3 K27M/G34R mutations drive abnormalities in PML nuclear bodiesHsiao P J Voon, Linda Hii, Andrew Garvie, et al.
Science Translational Medicine|November 20, 2015
Targeting LGR5+ cells with an antibody-drug conjugate for the treatment of colon cancerMelissa R Junttila, Weiguang Mao, Xi Wang, et al.
JCI Insight|January 23, 2025
Multidimensional, integrative profiling identifies BCL2L1 methylation as a predictor of MCL1 dependency in pediatric malignanciesShazia Adjumain, Paul Daniel, Claire Xin Sun, et al.
Pageof 7

Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
Molecular Cell|December 15, 2021
MED12 and BRD4 cooperate to sustain cancer growth upon loss of mediator kinaseDhanya Sooraj, Claire Sun, Anh Doan, et al.
The Journal of Clinical Investigation|August 25, 2022
CDK8 and CDK19 regulate intestinal differentiation and homeostasis via the chromatin remodeling complex SWI/SNFMarius V Dannappel, Danxi Zhu, Xin Sun, et al.
Cancer Research|March 30, 2013
A novel tankyrase small-molecule inhibitor suppresses APC mutation-driven colorectal tumor growthTed Lau, Emily Chan, Marinella Callow, et al.
Cell Metabolism|July 26, 2018
Pan-Cancer Metabolic Signature Predicts Co-Dependency on Glutaminase and De Novo Glutathione Synthesis Linked to a High-Mesenchymal Cell StateAnneleen Daemen, Bonnie Liu, Kyung Song, et al.
Molecular Cancer Therapeutics|September 25, 2014
An antimesothelin-monomethyl auristatin e conjugate with potent antitumor activity in ovarian, pancreatic, and mesothelioma modelsSuzie J Scales, Nidhi Gupta, Glenn Pacheco, et al.
Oncotarget|March 31, 2016
ImmunoPET helps predicting the efficacy of antibody-drug conjugates targeting TENB2 and STEAP1Simon-Peter Williams, Annie Ogasawara, Jeff N Tinianow, et al.
Nature|December 25, 2015
Targeting PTPRK-RSPO3 colon tumours promotes differentiation and loss of stem-cell functionElaine E Storm, Steffen Durinck, Felipe de Sousa e Melo, et al.
Genome Biology|December 9, 2023
Pediatric glioma histone H3.3 K27M/G34R mutations drive abnormalities in PML nuclear bodiesHsiao P J Voon, Linda Hii, Andrew Garvie, et al.
Science Translational Medicine|November 20, 2015
Targeting LGR5+ cells with an antibody-drug conjugate for the treatment of colon cancerMelissa R Junttila, Weiguang Mao, Xi Wang, et al.
JCI Insight|January 23, 2025
Multidimensional, integrative profiling identifies BCL2L1 methylation as a predictor of MCL1 dependency in pediatric malignanciesShazia Adjumain, Paul Daniel, Claire Xin Sun, et al.
Pageof 7